PRELIMINARY TRIAL OF POLY ICLC IN CHRONIC PROGRESSIVE MULTIPLE-SCLEROSIS

被引：20

作者：

BEVER, CT

SALAZAR, AM

NEELY, E

FERRARACCIO, BE

ROSE, JW

MCFARLAND, HF

LEVY, HB

MCFARLIN, DE

机构：

[1] NINCDS,NEUROIMMUNOL BRANCH,BLDG 10,RM 5B16,BETHESDA,MD 20205

[2] WALTER REED ARMY MED CTR,NEUROL SERV,WASHINGTON,DC 20307

[3] WALTER REED ARMY MED CTR,WASHINGTON,DC 20307

[4] NIAID,BETHESDA,MD 20205

来源：

NEUROLOGY | 1986年 / 36卷 / 04期

关键词：

D O I：

10.1212/WNL.36.4.494

中图分类号：

R74 [神经病学与精神病学];

学科分类号：

摘要：

引用

页码：494 / 498

页数：5

共 18 条

[1] A COMPARISON OF INTERFERON RESPONSES TO POLY ICLC IN MALES AND FEMALES [J].

BEVER, CT ;

MCFARLIN, DE ;

LEVY, HB .

JOURNAL OF INTERFERON RESEARCH, 1985, 5 (03) :423-428

[2] DESIGN OF CLINICAL STUDIES TO ASSESS THERAPEUTIC EFFICACY IN MULTIPLE-SCLEROSIS [J].

BROWN, JR ;

BEEBE, GW ;

KURTZKE, JF ;

LOEWENSON, RB ;

SILBERBERG, DH ;

TOURTELLOTTE, WW .

NEUROLOGY, 1979, 29 (09) :3-23

[3] INTERFERON IN SERUM AND CEREBROSPINAL-FLUID IN PATIENTS WITH MULTIPLE-SCLEROSIS AND OTHER NEUROLOGICAL DISORDERS [J].

DEGRE, M ;

DAHL, H ;

VANDVIK, B .

ACTA NEUROLOGICA SCANDINAVICA, 1976, 53 (02) :152-160

[4]

FOG T, 1980, SEARCH CAUSE MULTIPL, P490

[5] INTENSIVE IMMUNOSUPPRESSION IN PROGRESSIVE MULTIPLE-SCLEROSIS - A RANDOMIZED, 3-ARM STUDY OF HIGH-DOSE INTRAVENOUS CYCLOPHOSPHAMIDE, PLASMA-EXCHANGE, AND ACTH [J].

HAUSER, SL ;

DAWSON, DM ;

LEHRICH, JR ;

BEAL, MF ;

KEVY, SV ;

PROPPER, RD ;

MILLS, JA ;

WEINER, HL .

NEW ENGLAND JOURNAL OF MEDICINE, 1983, 308 (04) :173-180

[6] INTRATHECAL INTERFERON REDUCES EXACERBATIONS OF MULTIPLE-SCLEROSIS [J].

JACOBS, L ;

OMALLEY, J ;

FREEMAN, A ;

EKES, R .

SCIENCE, 1981, 214 (4524) :1026-1028

[7]

Johnson R T, 1975, Adv Neurol, V13, P1

[8] SYSTEMIC ALPHA-INTERFERON THERAPY OF MULTIPLE-SCLEROSIS [J].

KNOBLER, RL ;

PANITCH, HS ;

BRAHENY, SL ;

SIPE, JC ;

RICE, GPA ;

HUDDLESTONE, JR ;

FRANCIS, GS ;

HOOPER, CJ ;

KAMINLEWIS, RM ;

JOHNSON, KP ;

OLDSTONE, MBA ;

MERIGAN, TC .

NEUROLOGY, 1984, 34 (10) :1273-1279

[9]

LEVINE AS, 1979, CANCER RES, V39, P1645

[10]

LEVINE AS, 1981, AUGMENTING AGENTS CA, P151

← 1 2 →